BioXcel Therapeutics

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop innovative medicines with exceptional potency and selectivity. The platform, known as GEMS (Generative AI for Drug Discovery), combines AI and physics research to identify drug candidates against challenging targets at an accelerated pace. The company's approach involves designing highly potent and selective drugs for chemically complex targets, driven by a team of collaborative minds across AI and biotech disciplines. Genesis Therapeutics is dedicated to advancing breakthrough medicines and bringing new hope to patients through its unique blend of technology and expertise.

MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

DrugCard is an AI-enabled Data Intelligence platform designed to streamline drug safety routines, particularly in pharmacovigilance. It offers solutions for local literature screening, catering to CROs, MAHs, and freelancers in the pharmaceutical industry. The platform supports multiple languages, covers various medical journals, and saves significant time compared to manual approaches. DrugCard aims to enhance pharmacovigilance processes by leveraging AI, automation, and traceability to meet regulatory requirements and improve screening results.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay updated with the latest machine learning research. It provides access to over 240,000 ML papers, helps in understanding complex details, and automates literature reviews. The tool simplifies the process of discovering and accessing the most recent research developments in the field of machine learning.

NexusGPT is an AI tool that allows users to build and deploy custom AI agents for various workflows without the need for coding. It offers enterprise-grade AI solutions that can be integrated into any app, providing autonomous agents that can complete complex tasks, automate processes, and enhance productivity. With features like connecting to external plugins, enterprise-grade security, and deployment on existing apps, NexusGPT empowers users to create powerful AI agents effortlessly.

Emotion Logic Ltd is an AI tool that specializes in genuine emotion detection from voice data. The technology provides valuable insights across various sectors, including fraud investigations, healthcare, education, and customer service. Emotion Logic's advanced voice analysis capabilities help in deciphering unspoken emotions accurately, enhancing user experiences, and gaining valuable insights for decision-making processes.

functime is a time-series machine learning tool designed for scalability. It offers a comprehensive set of functions and features to facilitate time-series forecasting and analysis. With functime, users can easily install the tool, access documentation, tutorials, and API references. The tool provides scoring, ranking, and plotting functions for evaluating forecasts, making it a valuable resource for forecast analysts. Additionally, functime serves as an AI copilot, assisting users in analyzing trends, seasonality, and causal factors in their forecasts.

Kolank is an AI tool that offers a unified API with features such as load balancing, fallbacks, cost and performance metrics. Users can access models for generating text, images, and videos through simple API calls. The platform supports multiple programming languages like Python, JavaScript, and Curl, making it easy for developers to integrate AI capabilities into their applications.

Promptmakr is a platform that facilitates the buying and selling of AI prompts. It serves as a marketplace where users can find and purchase prompts for various AI applications. The platform aims to streamline the process of acquiring prompts, making it easier for developers and AI enthusiasts to access high-quality content to enhance their projects.

StockGPT is an AI-powered financial research assistant that provides knowledge of earnings releases, financial reports, and fundamental information for S&P 500 and Nasdaq companies. It offers features like AI search, customizable filters, up-to-date data, industry research, and more to help users analyze companies and markets efficiently.

Google Colab Copilot is an AI tool that integrates GitHub Copilot into Google Colab, allowing users to easily access AI-generated code suggestions while working on their projects. By following a simple setup guide, users can enhance their coding experience by leveraging the power of AI to assist with writing code snippets and improving productivity.

Lobe is a free and easy-to-use machine learning tool for Mac and PC that helps users train machine learning models and deploy them to any platform of their choice. It provides a user-friendly interface for creating and managing machine learning projects, making it accessible to both beginners and experienced users.

Aitodata.com is an AI tool designed to streamline data processing and analysis tasks. It offers a user-friendly interface that allows users to easily upload, clean, analyze, and visualize data sets. The tool leverages advanced machine learning algorithms to provide accurate insights and predictions, making it a valuable asset for data scientists, analysts, and researchers. With features such as data cleaning, exploratory data analysis, predictive modeling, and interactive visualizations, aitodata.com simplifies the data analysis process and helps users make informed decisions based on data-driven insights.

Shimoku is an AI tool that offers a catalog of AI modules for acquisition, conversion, loyalty, and retention, covering the entire customer lifecycle for marketers and sales teams. It combines Machine Learning, Explainability AI, and Generative AI to provide personalized solutions for various industries and sectors.

Weaviate is an AI-native database designed to empower developers in building and scaling modern AI applications more easily. It offers cloud, model, and deployment agnostic solutions, flexible cost-performance optimization, and a robust developer community. Weaviate enables lightning-fast pure vector similarity search over raw vectors or data objects, even with filters. The platform is open source and supports integrations with various language model frameworks, making it a versatile tool for AI development.

Chessvision.ai is an AI-powered eBook reader that leverages Artificial Intelligence and Computer Vision to make chess eBooks interactive. It supports PDF, ePub, and DjVu formats, allowing users to analyze chess diagrams, add comments, search positions online, watch YouTube videos, and analyze with the engine. The application has gained popularity among chess players of all levels for its ability to enhance the study and learning experience through innovative technology.

ThirdAI is a production-ready AI platform designed for enterprises, offering out-of-the-box solutions that work at scale with 10x better price performance. It provides enterprise-grade productivity tools like document search & retrieval, content creation, FAQ bots, customer live support, hyper-personalization, risk & compliance, fraud detection, anomaly detection, and PII/sensitive data redaction. The platform allows users to bring their business problems, apply on their data, and compose AI applications without the need for extensive POC cycles or manual fine-tuning. ThirdAI focuses on low latency, security, scalability, and performance, enabling business leaders to solve critical needs in weeks, not months or years.

Susterra is an advanced analytics platform for Public Finance stakeholders, aiming to catalyze urban development by providing powerful insights. The platform integrates leading practices from academia, utilizes public data for creating relevant insights, and leverages technology innovations like ML and AI. Susterra offers solutions such as TerraScore, TerraVision, TerraView, and Impact IQ, enabling evaluation of public benefit programs in various sectors. The platform also specializes in data visualization tools and is powered by Google Cloud.

The AI SDK by Vercel is a free open-source library designed to empower developers with the necessary tools to create AI-powered products. It offers a Unified Provider API that allows easy switching between AI providers with just a single line of code. Developers can build generative UIs, utilize framework-agnostic features, and ensure instant AI responses for users. The SDK has received positive feedback from builders for its ease of use and efficiency in building AI features within minutes.

DecodeAI is an experimental concept for an automatic blog about AI, generated by AI and curated by humans. The blog mainly focuses on AI-related GitHub open-source repositories. It features tools like Cody, an AI coding assistant that can write and fix code, provide autocomplete suggestions, and answer coding questions. Another tool, Jan, is an open-source alternative to ChatGPT that allows running AI models offline on a desktop. Additionally, Open Interpreter is an open-source project enabling language models to execute code locally through a human-like interface in the terminal.

AnyAPI is an AI tool that allows users to easily add AI features to their products in minutes. With the ability to craft the perfect GPT-3 prompt using A/B testing, users can quickly generate a live API endpoint to power their next AI feature. The platform offers a range of use cases, including turning emails into tasks, suggesting replies, and obtaining plain text JSON from GPT3. AnyAPI is designed to streamline the integration of AI capabilities into various products and services, making it a valuable tool for developers and businesses seeking to leverage AI technology.